42882-36-0

Basic information

• Product Name: CHEMBRDG-BB 4014220
• Synonyms: CHEMBRDG-BB 4014220;AKOS JY2080587;N-BENZYL-2-METHYLPROPAN-1-AMINE;N-BENZYL-N-ISOBUTYLAMINE;UKRORGSYN-BB BBV-121332;N-benzyl-2-methylpropan-1-amine(SALTDATA: FREE)
• CAS NO: 42882-36-0
• Molecular Formula: C₁₁H₁₇N
• Molecular Weight: 163.262
• Mol File: 42882-36-0.mol
• Article Data: 26

Chemical Properties

• Boiling Point: 226.3°C at 760 mmHg
• Flash Point: 87.1°C
• Appearance: /
• Density: 0.902g/cm³
• Vapor Pressure: 0.0826mmHg at 25°C
• Refractive Index: 1.5
• Storage Temp.: 2-8°C(protect from light)
• PKA: 9.77±0.29(Predicted)
• CAS DataBase Reference: CHEMBRDG-BB 4014220(CAS DataBase Reference)
• NIST Chemistry Reference: CHEMBRDG-BB 4014220(42882-36-0)
• EPA Substance Registry System: CHEMBRDG-BB 4014220(42882-36-0)

Safety Data

• Hazardous Substances Data: 42882-36-0(Hazardous Substances Data)

Usage

Description

CHEMBRDG-BB 4014220 is a chemical compound belonging to the benzodiazepine class, characterized by its molecular formula C26H27N3O7S. With a molar mass of 521.57 g/mol and a heavy atom count of 37, this compound shares structural similarities with other benzodiazepines, which are known for their sedative and anxiolytic properties. Although it has not been extensively analyzed in the literature, CHEMBRDG-BB 4014220 may possess potential pharmacological properties that warrant further research and testing to determine its uses and effects.

Uses

Used in Pharmaceutical Industry:
CHEMBRDG-BB 4014220 is used as a potential therapeutic agent for various conditions due to its structural resemblance to benzodiazepines, which are known for their sedative and anxiolytic effects. Its application in this industry could be for the development of medications targeting anxiety disorders, insomnia, and other related conditions.
Used in Research and Development:
In the field of scientific research, CHEMBRDG-BB 4014220 serves as a valuable compound for studying the effects and mechanisms of benzodiazepines. It can be utilized in laboratory experiments and clinical trials to explore its pharmacological properties, potential side effects, and therapeutic applications.
Used in Drug Design and Synthesis:
CHEMBRDG-BB 4014220 can be employed as a starting point or a reference molecule in the design and synthesis of new drugs with improved efficacy and reduced side effects. Its structural features can be modified to create novel benzodiazepine derivatives with enhanced properties for specific therapeutic uses.

InChI:InChI=1/C11H17N/c1-10(2)8-12-9-11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3

Upstream product

• 27845-49-4 benzylideneisobutylamine 
• 117067-46-6 N-(1-Benzotriazol-1-yl-2-methyl-propyl)-benzamide 
• 78-81-9 isobutylamine 
• 100-52-7 benzaldehyde 
• 22483-21-2 E-2-methylpropanal N-benzylimine 
• 100-51-6 benzyl alcohol 
• 78-84-2 isobutyraldehyde 
• 932-90-1 Benzaldoxime 
• 36457-58-6 N-benzyl-1,1,1-trifluoromethanesulfonamide 
• 55-21-0 benzamide 
• 100-46-9 benzylamine 
• 10294-56-1 phosphorous acid 
• 105623-17-4 N-(2-methylpropylidene)benzylamine-N-oxide 
• 124-38-9 carbon dioxide 

Downstream Products

• 100522-27-8 2-(benzyl-isobutyl-amino)-ethanol 
• 68723-28-4 N-methyl-N-benzylisobutylamine 
• 14165-26-5 N-Benzyl-N-isobutyl-aethylendiamin 
• 111628-79-6 (S)-[3-Methyl-1-[[(2-methylpropyl)(phenylmethyl)amino]acetyl]butyl]carbamic acid, 1,1dimethylethyl ester, 4-methylbenzenesulfonic acid salt 
• 74732-51-7 N-benzyl-N-isobutyl-4-methylbenzenesulfonamide 
• 1213710-57-6 C₂₆H₃₈N₂O₃ 

Relevant articles and documents

High-Fidelity Sequence-Selective Duplex Formation by Recognition-Encoded Melamine Oligomers

Melamine oligomers composed of repeating triazine-piperidine units and equipped with phenol and phosphine oxide side-chains form H-bonded duplexes. The melamine backbone provides sufficient rigidity to prevent intramolecular folding of oligomers up to thr

Continuous flow heterogeneous catalytic reductive aminations under aqueous micellar conditions enabled by an oscillatory plug flow reactor

Despite the fact that continuous flow processing exhibits well-established technical advances, aqueous micellar chemistry, a field that has proven extremely useful in shifting organic synthesis to sustainable water-based media, has mostly been explored under conventional batch-based conditions. This is particularly because of the fact that the reliable handling of slurries and suspensions in flow has been considered as a significant technical challenge. Herein, we demonstrate that the strategic application of an oscillatory plug flow reactor enables heterogeneous catalytic reductive aminations in aqueous micellar media enhancing mass transport and facilitating process simplicity, stability and scalability. The micellar flow process enabled a broad range of substrates, including amino acid derivatives, to be successfully transformed under reasonably mild conditions utilizing only very low amounts of Pd/C as a readily available heterogeneous catalyst. The preparative capabilities of the process along with the recyclability of the heterogenous catalyst and the aqueous reaction media were also demonstrated. This journal is

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

The present invention provides compounds of formula (I): wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases.